U.S. Supreme Court Rejects Appeal Over Patents for Off-Market Uses of Drugs
In a setback for research-based drugmakers, the U.S. Supreme Court declined to hear an appeal over patent rights for drugs prescribed for off-market uses....To view the full article, register now.
Already a subscriber? Click here to view full article